Home » Press Room » Client Alerts & Other Resources » The Future of the 340B Drug Pricing Program: Challenges and Opportunities

The Future of the 340B Drug Pricing Program: Challenges and Opportunities

Fri, 09/16/2011

To view this research policy paper authored by Jeffrey Lewis, President of PS2 Health Care, please click here:

The Future of the 340B Drug Pricing Program: Challenges and Opportunities

  • Printer-friendly version
  • Send to friend